Next Article in Journal
An Electrochemical Enzyme Biosensor for 3-Hydroxybutyrate Detection Using Screen-Printed Electrodes Modified by Reduced Graphene Oxide and Thionine
Next Article in Special Issue
Label-Free Biosensor Detection of Endocrine Disrupting Compounds Using Engineered Estrogen Receptors
Previous Article in Journal
Encapsulation-Stabilized, Europium Containing Nanoparticle as a Probe for Time-Resolved luminescence Detection of Cardiac Troponin I
Article Menu
Issue 4 (December) cover image

Export Article

Open AccessReview
Biosensors 2017, 7(4), 49; https://doi.org/10.3390/bios7040049

Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development

Pall Fortebio, 47661 Fremont Boulevard, Fremont, CA 94538, USA
Received: 14 September 2017 / Revised: 26 October 2017 / Accepted: 28 October 2017 / Published: 31 October 2017
(This article belongs to the Special Issue Label-free Biosensing)
Full-Text   |   PDF [3459 KB, uploaded 31 October 2017]   |  

Abstract

Bio-layer interferometry (BLI) real-time, label-free technology has greatly contributed to advances in vaccine research and development. BLI Octet platforms offer high-throughput, ease of use, reliability, and high precision analysis when compared with common labeling techniques. Many different strategies have been used to immobilize the pathogen or host molecules on BLI biosensors for real-time kinetics and affinity analysis, quantification, or high-throughput titer. These strategies can be used in multiple applications and shed light onto the structural and functional aspects molecules play during pathogen-host interactions. They also provide crucial information on how to achieve protection. This review summarizes some key BLI strategies used in human vaccine research and development. View Full-Text
Keywords: BLI; vaccine; biosensor; label-free; real-time BLI; vaccine; biosensor; label-free; real-time
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Petersen, R.L. Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development. Biosensors 2017, 7, 49.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Biosensors EISSN 2079-6374 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top